Vectorite Biomedical Inc. (TPEX:4170)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
12.30
0.00 (0.00%)
Aug 4, 2026, 1:22 PM CST

Vectorite Biomedical Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
569613635935621621
Market Cap Growth
11.11%-3.45%-32.08%50.46%0%26.25%
Enterprise Value
399437442728396375
Last Close Price
13.0014.0014.5021.3514.0114.01

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
5.946.37---74.32
PS Ratio
9.279.9810.9916.7314.4721.59
PB Ratio
1.171.261.632.171.411.33
P/TBV Ratio
1.171.261.662.291.491.40
P/FCF Ratio
----44.96-
P/OCF Ratio
---719.9742.25-

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
6.507.127.6513.049.2313.03
EV/FCF Ratio
----28.67-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.00----
Net Debt / Equity Ratio
-0.35-0.35-0.47-0.47-0.48-0.51
Net Debt / EBITDA Ratio
12.2312.2310.7429.219.859.23
Net Debt / FCF Ratio
17.4017.4012.8858.92-15.463.54
Asset Turnover
0.130.130.130.120.090.07
Inventory Turnover
2.672.673.295.316.994.97
Quick Ratio
10.7310.7312.9116.4514.1014.53
Current Ratio
11.8511.8514.0617.5314.9315.07
Return on Equity (ROE)
21.98%21.98%-9.77%-1.52%-5.83%2.05%
Return on Assets (ROA)
-2.97%-2.97%-3.75%-2.20%-3.98%-6.15%
Return on Capital Employed (ROCE)
-4.40%-4.40%-6.50%-3.70%-6.80%-8.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
16.90%15.69%-6.31%-0.71%-4.25%1.35%
FCF Yield
-1.72%-1.60%-2.26%-0.37%2.22%-10.88%
Buyback Yield / Dilution
-0.53%-0.53%0.14%--1.84%-47.01%